Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
10/2006
10/18/2006EP1711463A2 Amino-substituted tricyclic derivatives and methods of use
10/18/2006EP1711175A1 Diurea derivatives
10/18/2006EP1572683B1 Novel piperidine derivatives as modulators of chemokine receptor ccr5
10/18/2006CN1849308A Thiophenylaminoimidazolines
10/18/2006CN1849307A Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists
10/18/2006CN1280275C Pyridione derivatives for tretment of atherosclerosis
10/18/2006CN1280273C Synthesis of donepizin and its derivative
10/18/2006CN1280267C Sulfonylaminocarboxylic acids
10/17/2006US7122677 NK1 antagonists
10/17/2006US7122675 Gamma secretase inhibitors
10/17/2006US7122668 Platinum complexes and their use in therapy
10/17/2006US7122663 Oxidation of alcohols to aldehydes, ketones, acids
10/17/2006US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc
10/17/2006US7122539 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications.
10/17/2006US7122506 heterocyclic imines such as 2-(2,6-difluorophenyl)-5-phenyl-3,4-dihydro-2H-pyrrole, formed by cyclocondensation, for use as insecticides or miticides
10/17/2006CA2318527C Inhibitors of .alpha.4 mediated cell adhesion
10/17/2006CA2244774C Dihydropyridine derivatives, their preparation and their use as adenosine receptor antagonists
10/17/2006CA2238818C 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists
10/12/2006WO2006107106A1 Ligand for vesicular acetylcholine transporter
10/12/2006WO2006106727A1 Benzyloxypropylamine derivative
10/12/2006WO2006106241A1 Piperazine derivatives and use thereof as serotonin reuptake inhibitors or as neurokinin antagonists
10/12/2006WO2006064351A3 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors
10/12/2006WO2006060225A3 Process for asymmetric synthesis of hexahydropyrimido[1,2-a] azepine-2-carboxamides and related compounds
10/12/2006WO2006050239A3 Muscarinic acetylcholine receptor antagonists
10/12/2006US20060229452 Process for the oxidation of secondary amines into the corresponding nitroxides
10/12/2006US20060229336 HIV, acquired immune deficiency syndrome (AIDS); 1-(8-{2-[1-(2,2-Dimethylpropanoyl)-4-phenylpiperidin-4-yl]ethyl}-8-azabicyclo[3.2.1]oct-3-yl)-2-methyl-1H-benzimidazole
10/12/2006US20060229334 Biphenyl derivatives
10/12/2006US20060229317 Substituted heterocyclic compounds
10/12/2006US20060229298 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
10/12/2006US20060226766 Electroluminescent device
10/12/2006CA2603030A1 Benzyloxypropylamine derivative
10/11/2006EP1710240A1 Piperazine derivatives and their use as serotonin reuptake inhibitors or as neurokinin antagonists
10/11/2006EP1710238A1 Benzophenones as inhibitors of reverse transcriptase
10/11/2006EP1710235A1 Extracts of marasmins androsaceus l.es, piperdinone derivatives and the use as antihypertensive agents
10/11/2006EP1710231A1 CETP activity inhibitors
10/11/2006EP1709029A2 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
10/11/2006EP1709000A1 Piperidine derivatives as gcs inhibitors
10/11/2006EP1708994A1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
10/11/2006EP1708704A2 4-aryl piperidines
10/11/2006EP1708702A2 Novel m3 muscarinic acetylcholine receptor antagonists
10/11/2006EP1708698A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
10/11/2006EP1469851B1 Melanocortin receptor agonists
10/11/2006CN1844105A Beta-elemene derivatives containing nitrogen and their preparation method and use
10/11/2006CN1844099A Process for preparation of tirofiban hydrochloride
10/11/2006CN1279024C Process for the preparation of stabilizers for polymers
10/10/2006US7119206 drugs such as 12-[4-(2-Piperidin-1-yl-ethoxy)-phenyl]-7,12-dihydro-benzo[a]anthracene-3,9-diol, used for prevention of bone and cardiovascular disorders, as hypotensive, thrombolytic and anticholesterol agents
10/10/2006US7119203 Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
10/10/2006US7119109 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
10/10/2006US7119092 Chemical compounds
10/10/2006CA2219678C Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection or associated diseases
10/05/2006WO2006105304A2 Phenyl and pyridyl lta4h modulators
10/05/2006WO2006105127A2 Hydroxysteroid dehydrogenase inhibitors
10/05/2006WO2006104280A1 Prophylactic/therapeutic agent for diabetes
10/05/2006WO2006103692A1 Novel polymeric hindered amine light stabilizers based on end functionalized polyolefins and a process for the preparation thereof.
10/05/2006WO2006103527A1 Aromatic substituted pentadienoic acid amide for combination with anti-infective drugs
10/05/2006WO2006103275A1 3,4,5-substituted piperidines as renin inhibitors
10/05/2006WO2006103120A2 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
10/05/2006WO2006102760A1 Inhibitors of histone deacetylase
10/05/2006WO2006058064A3 Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
10/05/2006WO2004060308A3 Thiosemicarbazones as anti-virals and immunopotentiators
10/05/2006US20060223861 Derivatives of N-[phenyl(alkylpiperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
10/05/2006US20060223860 e.g. 3-(4-{[6-({(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)-phenyl]ethyl}amino)-hexyl]oxy}butyl)benzenesulfonamide; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist activity; bronchodilator agent; pulmonary disorders: chronic obstructive pulmonary dusease; asthma
10/05/2006US20060223859 Chronic obstructive pulmonary dusease; asthma
10/05/2006US20060223858 Chronic obstructive pulmonary dusease; asthma
10/05/2006US20060223855 reduces or inhibits amyloid fibril formation, organ specific dysfunction (e.g., neurodegeneration), or cellular toxicity
10/05/2006US20060223853 e.g. 1-[2-hydroxy-3-(quinolin-5-yloxy)-propyl]-piperidine-4-carboxylic acid [4-phenyl-1-(3-phenyl-propyl)-butyl]-amide; multidrug resistance protein or P-glycoprotein modulator; with other therapeutic agent: anticarcinogenic, antibacterial, antiviral, antifungal agents
10/05/2006US20060223840 Substituted piperidine compounds and methods of their use
10/05/2006US20060223814 Nk-2 antagonist basic linear compounds and formulations containing them
10/05/2006US20060223792 Phenyl and pyridyl LTA4H modulators
10/05/2006US20060223784 Method and compositions for temporarily incapacitating subjects
10/05/2006CA2603589A1 Inhibitors of histone deacetylase
10/05/2006CA2603345A1 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
10/05/2006CA2603122A1 Phenyl and pyridyl lta4h modulators
10/05/2006CA2601108A1 3,4,5-substituted piperidines as renin inhibitors
10/04/2006EP1707560A1 Hydroxamic acid derivative and age generation inhibitor containing the derivative
10/04/2006EP1706409A1 Compounds useful in therapy
10/04/2006EP1706402A1 Cathepsin cysteine protease inhibitors
10/04/2006EP1706380A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
10/04/2006EP1706379A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
10/04/2006EP1706375A2 Substituted n-aryl amidines as selective d1 dopamine receptor antagonists for the treatment of obesity and cns disorders
10/04/2006EP1534658A4 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
10/04/2006EP1423392B1 Derivatives of morphine-like opioid compounds
10/04/2006EP1377290B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/04/2006EP1372653B1 Acylated piperidine derivatives as melanocortin-4 receptor agonists
10/04/2006CN1842517A 芴衍生物 Fluorene derivatives
10/04/2006CN1842335A Ophthalmic compositions for treating ocular hypertension
10/04/2006CN1842330A Glycosidase inhibitors and methods of synthesizing same
10/03/2006US7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/03/2006US7115767 Tetraline derivatives as ghrelin receptor modulators
10/03/2006US7115750 Melanin concentrating hormone antagonist
10/03/2006US7115646 Cyclic diamines and derivatives as factor Xa inhibitors
10/03/2006US7115638 Amide derivative of amlodipine
10/03/2006US7115634 4-aminopiperidine and their use as a medicine
10/03/2006US7115633 Benzosuberonylpiperdine compounds as analgesics
10/03/2006US7115632 Sulfonyl aryl or heteroaryl hydroxamic acid compounds
10/03/2006US7115631 Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
10/03/2006US7115618 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
10/03/2006US7115610 Substituted heterocyclic compounds
10/03/2006US7115609 Compounds containing particular phenyl, indolyl or benzo[b]thiophenyl groups, a glycine residue bearing a substituted alkyl group and a 4-(1-methyl-piperidin-4-yl)piperidin-1-yl or 4-(1-methylpiperidin-4-yl)piperazin-1-yl group; Factor Xa inhibitors, thrombotic disorder
10/03/2006US7115607 Substituted piperazinyl amides and methods of use